IAIM
NVCR icon

International Assets Investment Management’s NovoCure NVCR Stock Holding History

International Assets Investment Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6
Closed -$1K – 1422
2021
Q1 		$1K Hold
6
– – ﹤0.01% 2134
2020
Q4 		$1K Buy
+6
New +$821 ﹤0.01% 2015

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

International Assets Investment Management's NVCR Position: Q2 2021 in Review

International Assets Investment Management sold out of NovoCure (NVCR) in Q2 2021, closing a stake of 6 shares — an estimated $1K sold.

International Assets Investment Management first reported a position in NVCR in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 362 funds tracked by Wall St. Rank hold NVCR as of Q2 2021.

  • International Assets Investment Management reported no remaining NovoCure position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 6 NovoCure shares in Q2 2021, an estimated $1K.
  • International Assets Investment Management first reported a position in NovoCure in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's NovoCure position peaked at $1K in Q1 2021.
  • 362 funds tracked by Wall St. Rank held NovoCure as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.